![](/img/cover-not-exists.png)
Randomized Phase II Study of the Anti-Epidermal Growth Factor Receptor Monoclonal Antibody Cetuximab With Cisplatin Versus Cisplatin Alone in Patients With Metastatic Triple-Negative Breast Cancer
Baselga, J., Gomez, P., Greil, R., Braga, S., Climent, M. A., Wardley, A. M., Kaufman, B., Stemmer, S. M., Pego, A., Chan, A., Goeminne, J.-C., Graas, M.-P., Kennedy, M. J., Ciruelos Gil, E. M., SchneVolume:
31
Language:
english
Journal:
Journal of Clinical Oncology
DOI:
10.1200/JCO.2012.46.2408
Date:
July, 2013
File:
PDF, 172 KB
english, 2013